A New Grand Bargain to Improve the Antimicrobial Market for Human Health
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
Study Group on Technology, Comparative Advantage, and Development Prospects
August 30, 2018
Advances in artificial intelligence, robotics, and information and communications technology have the potential to transform a range of industries and services around the world. While the effects of these changes in OECD countries have been broadly researched, their potential impacts in the developi...
The Unintended Consequences of Rich Countries’ Anti–Money Laundering Policies on Poor Countries
January 23, 2015
The Unintended Consequences of Rich Countries’ Anti-Money Laundering Policies on Poor Countries Working Group examined how rich countries might rebalance their policies to continue to protect against money laundering and terrorism financing without hindering the ability of people from poor countries...
Drug Resistance Working Group (November 2007 – June 2010)
September 10, 2014
Value for Money: An Agenda for Global Health Funding Agencies
August 25, 2014
As international commitments become more ambitious and aid resources become increasingly constrained, global health funding agencies are seeking to improve the efficiency and impact of their investments. This growing “value for money” (VfM) agenda aims to reduce costs, increase imp...